Literature DB >> 2381446

Hyperlipidemia in the nephrotic syndrome.

W F Keane, B L Kasiske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2381446     DOI： 10.1056/NEJM199008303230910

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

2.  Lipid Profile In Transplant Patients: A Clinical Study.

Authors:  K V Baliga; P K Sharma; M S Prakash; M Mostafi
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Apolipoprotein E polymorphism and clinical course in childhood nephrotic syndrome.

Authors:  Sung-Do Kim; Il-Soo Kim; Byung-Cheol Lee; Kang-Duk Choi; Joo-Ho Chung; Chun-Gyoo Ihm; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2003-02-13       Impact factor: 3.714

4.  Renal apolipoproteins in nephrotic rats.

Authors:  H van Goor; M L van der Horst; J Atmosoerodjo; J A Joles; A van Tol; J Grond
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

5.  Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  Anand Srivastava; Beverley Adams-Huet; Gloria L Vega; Robert D Toto
Journal:  J Investig Med       Date:  2016-07-07       Impact factor: 2.895
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.